Jena scientist receives grant for research on mitochondrial and neurodegenerative disease treatments

Eli Lil­ly’s Retev­mo to treat ad­vanced or metasta­t­ic re­arranged dur­ing trans­fec­tion (RET)-mu­tant medullary thy­roid can­cer (MTC) showed promis­ing re­sults at im­prov­ing pro­gres­sion-free sur­vival com­pared to

Xy­lo­Cor Ther­a­peu­tics has closed a $67.5 mil­lion Se­ries B round to fund mid-stage de­vel­op­ment of its car­diac gene ther­a­py. Two years ago, the biotech said